Matches in Wikidata for { <http://www.wikidata.org/entity/Q58622171> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q58622171 description "article scientifique publié en 1997" @default.
- Q58622171 description "article" @default.
- Q58622171 description "im Dezember 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58622171 description "wetenschappelijk artikel" @default.
- Q58622171 description "наукова стаття, опублікована в грудні 1997" @default.
- Q58622171 name "Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides" @default.
- Q58622171 name "Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides" @default.
- Q58622171 type Item @default.
- Q58622171 label "Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides" @default.
- Q58622171 label "Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides" @default.
- Q58622171 prefLabel "Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides" @default.
- Q58622171 prefLabel "Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides" @default.
- Q58622171 P1433 Q58622171-7C2B498F-70C9-4F7B-9496-2EF477E16600 @default.
- Q58622171 P1476 Q58622171-4438A12F-368D-43DA-8DAA-B363F1689CC1 @default.
- Q58622171 P2093 Q58622171-089D9EE4-C0B4-4540-BCCB-33DC565FF0FA @default.
- Q58622171 P2093 Q58622171-26A92418-F156-43FD-BE10-81871E571446 @default.
- Q58622171 P2093 Q58622171-2AE24369-ED6F-4BF8-8577-36D4CD64948F @default.
- Q58622171 P2093 Q58622171-2B14A1BD-14C2-4909-BC92-E1ABB0C90C4D @default.
- Q58622171 P2093 Q58622171-39450991-70C9-4522-94F5-6C31B985387D @default.
- Q58622171 P2093 Q58622171-5CB2D128-6767-4F93-9F25-B0AD7427D6E6 @default.
- Q58622171 P2093 Q58622171-830CC685-00C8-4C84-AA32-E12715B25150 @default.
- Q58622171 P2093 Q58622171-96647817-F888-4202-90E8-5E1127200929 @default.
- Q58622171 P2093 Q58622171-9D241D76-5385-4675-B451-C3C69D3FCB14 @default.
- Q58622171 P2093 Q58622171-E33E6E4D-C731-47C5-A90E-CCB2CEFB5035 @default.
- Q58622171 P2093 Q58622171-E501EEAB-0289-4B41-957B-8D1181E6CC41 @default.
- Q58622171 P2093 Q58622171-EC773F12-2EF7-4655-BBEE-933300E1D9D2 @default.
- Q58622171 P2093 Q58622171-F7BCD7BC-EA8F-4045-81E1-82E343629082 @default.
- Q58622171 P304 Q58622171-CDB2CF88-9302-4E55-9F2F-3250CE508D62 @default.
- Q58622171 P31 Q58622171-F3F95FF3-16D1-4DB7-A590-D237B803BE05 @default.
- Q58622171 P356 Q58622171-BF9515E1-B9E0-40BA-8EF3-6D0F80FF051A @default.
- Q58622171 P407 Q58622171-F5B077D2-A9A8-4A6C-A88F-7BB71D19EC11 @default.
- Q58622171 P433 Q58622171-EBA21C95-5E89-4EC3-9B1C-4AF99E3BDF65 @default.
- Q58622171 P478 Q58622171-7ABDC72A-F1AD-47F2-AE84-725DF829B675 @default.
- Q58622171 P50 Q58622171-913E38E2-31FD-4EE4-B397-D5A0EE2CA4C3 @default.
- Q58622171 P577 Q58622171-0192BAFF-4BC2-4E0A-A3DC-DD37629D1C7C @default.
- Q58622171 P698 Q58622171-B8D243B5-1780-40D1-82CF-A4AD3251E43B @default.
- Q58622171 P921 Q58622171-9D604E70-2A90-4136-8068-203A3E0A5529 @default.
- Q58622171 P921 Q58622171-B5C60D98-83AD-470D-906A-C96BE256D60E @default.
- Q58622171 P356 36.12.1290 @default.
- Q58622171 P698 9448590 @default.
- Q58622171 P1433 Q27709787 @default.
- Q58622171 P1476 "Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides" @default.
- Q58622171 P2093 "B Christoforov" @default.
- Q58622171 P2093 "B Godeau" @default.
- Q58622171 P2093 "E Vidal" @default.
- Q58622171 P2093 "F Lhote" @default.
- Q58622171 P2093 "J P Ducroix" @default.
- Q58622171 P2093 "L Guillevin" @default.
- Q58622171 P2093 "M Gayraud" @default.
- Q58622171 P2093 "M Piontud" @default.
- Q58622171 P2093 "M Ruel" @default.
- Q58622171 P2093 "P Babinet" @default.
- Q58622171 P2093 "P Cohen" @default.
- Q58622171 P2093 "P Deblois" @default.
- Q58622171 P2093 "S Lassoued" @default.
- Q58622171 P304 "1290-1297" @default.
- Q58622171 P31 Q13442814 @default.
- Q58622171 P356 "10.1093/RHEUMATOLOGY/36.12.1290" @default.
- Q58622171 P407 Q1860 @default.
- Q58622171 P433 "12" @default.
- Q58622171 P478 "36" @default.
- Q58622171 P50 Q42226825 @default.
- Q58622171 P577 "1997-12-01T00:00:00Z" @default.
- Q58622171 P698 "9448590" @default.
- Q58622171 P921 Q32811 @default.
- Q58622171 P921 Q745162 @default.